Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Pharmacological Research
|
January 1, 1992
Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients
E Spina, G M Campo, S Calandra, et al.
Radiologia
|
May 28, 2021
Imaging manifestations of pulmonary melioidosis: a case series
J A Carrillo-Bayona, A M Alvarado-Benavides, J Y Rodríguez, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Debrisoquine oxidation phenotype during neuroleptic monotherapy
E Spina, C Martines, A P Caputi, et al.
Therapeutic Drug Monitoring
|
August 15, 2000
Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine
J A Carrillo, M Christensen, S I Ramos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 24, 2009
Development and evaluation of a multiplex test for the detection of atypical bacterial DNA in community-acquired pneumonia during childhood
J A Carrillo, J Gutiérrez, F García, et al.
Clinical Pharmacology and Therapeutics
|
December 2, 1998
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors
E Arlander, G Ekström, C Alm, et al.
Plant Disease
|
February 9, 2019
First Report of Blue Mold Caused by Penicillium oxalicum in Tomato (Solanum lycopersicum) in Mexico
P A Picos-Munoz, R S Garcia-Estrada, J A Carrillo-Fasio, et al.
BMC Infectious Diseases
|
July 7, 2018
Comparison of qPCR and culture methods for group B Streptococcus colonization detection in pregnant women: evaluation of a new qPCR assay
J A Carrillo-Ávila, J Gutiérrez-Fernández, A I González-Espín, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Polymorphic oxidation of debrisoquine in lung cancer patients
J Benítez, J M Ladero, C Jara, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1999
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists
C Martínez, C Albet, J A Agúndez, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Pharmacological Research
|
January 1, 1992
Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients
E Spina, G M Campo, S Calandra, et al.
Radiologia
|
May 28, 2021
Imaging manifestations of pulmonary melioidosis: a case series
J A Carrillo-Bayona, A M Alvarado-Benavides, J Y Rodríguez, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Debrisoquine oxidation phenotype during neuroleptic monotherapy
E Spina, C Martines, A P Caputi, et al.
Therapeutic Drug Monitoring
|
August 15, 2000
Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine
J A Carrillo, M Christensen, S I Ramos, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 24, 2009
Development and evaluation of a multiplex test for the detection of atypical bacterial DNA in community-acquired pneumonia during childhood
J A Carrillo, J Gutiérrez, F García, et al.
Clinical Pharmacology and Therapeutics
|
December 2, 1998
Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors
E Arlander, G Ekström, C Alm, et al.
Plant Disease
|
February 9, 2019
First Report of Blue Mold Caused by Penicillium oxalicum in Tomato (Solanum lycopersicum) in Mexico
P A Picos-Munoz, R S Garcia-Estrada, J A Carrillo-Fasio, et al.
BMC Infectious Diseases
|
July 7, 2018
Comparison of qPCR and culture methods for group B Streptococcus colonization detection in pregnant women: evaluation of a new qPCR assay
J A Carrillo-Ávila, J Gutiérrez-Fernández, A I González-Espín, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Polymorphic oxidation of debrisoquine in lung cancer patients
J Benítez, J M Ladero, C Jara, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1999
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists
C Martínez, C Albet, J A Agúndez, et al.
Page
of 5